Generate Biomedicines

Founded: 2018 · Somerville, Massachusetts, United States · 201-500 employees · Private

About Generate Biomedicines

Generate Biomedicines is a therapeutics company pioneering generative biology at the intersection of machine learning, biological engineering, and medicine to create breakthrough medicines. It operates as a developer of a machine learning-powered biomedicines platform with the potential to generate new drugs across a wide range of biologic modalities.

Company Details

Website: https://www.generatebiomedicines.com
Funding: Series C
Total Raised: $693M
LinkedIn: https://www.linkedin.com/company/generate-biomedicines

Specializations

Generative Biology
AI/ML
Drug Discovery
Biotechnology
Protein Engineering

Products & Solutions (4)

Product	Category	Sub-Category	Description
GB-0669	research-development	Drug Discovery AI	AI-designed monoclonal antibody for durable neutralization of SARS-CoV-2.
GB-0895	research-development	Drug Discovery AI	Long-acting anti-TSLP antibody for severe asthma, advancing to Phase 3.
GB-7624	research-development	Drug Discovery AI	Anti-IL-13 therapeutic for atopic dermatitis, entering Phase 1 trial in early 2025.
Generate Platform	research-development	Drug Discovery AI	Generative AI for protein therapeutics design